Hemay Pharma Completes Series D Financing for Autoimmune and Oncology Drugs
China-based Ganzhou Hemay Pharmaceutical Co., Ltd, an innovative drug developer focused on autoimmune diseases and...
Neurodawn Completes Series A+ Financing for CNS Drug Development
Neurodawn Pharmaceutical Co., Ltd, a central nervous system (CNS) drug developer based in Nanjing, has...
Grand Pharma Completes Patient Enrollment for STC3141 Sepsis Study
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced that all patients have completed enrollment...
Eyebright Medical Gains SIX Swiss Exchange Approval for GDR Offering
Beijing-based ophthalmic device maker Eyebright Medical Technology Co., Ltd (SHA: 688050) has announced receiving conditional...
Teddy Clinical Research Lab Partners with Cerba Research for Global Services
China-based Teddy Clinical Research Laboratory Limited, a joint venture (JV) between Dian Diagnostics (SHE: 300244)...
Junshi Biosciences’ COVID-19 Therapy Faces Supply Issues, Partners with Sihuan Pharma
Junshi Biosciences’ (HKG: 1877, SHA: 688180) COVID-19 therapy JT001 (VV116) appears to be facing supply...
Macrolux Secures Series A Funding for Endoscopy Solutions
Macrolux, an endoscopy intervention solutions provider based in Shenzhen, has reportedly raised close to RMB...
Hua Medicine Receives Milestone Payment from Bayer for Dorzagliatin
China-based Hua Medicine has announced receiving a RMB 400 million (USD 59 million) milestone payment...
SciClone Pharmaceuticals Files for Hong Kong Market Approval of Danyelza
SciClone Pharmaceuticals Inc. (Nasdaq: SCLN), which became a China-based company after going private in 2017,...
Asia Regenerative Medicine Raises Pre-Series A+ Funding for Bioartificial Organs
Shenzhen-based Asia Regenerative Medicine (ARM) has reportedly raised “tens of millions” of renminbi in a...
Beijing Smart Beam Raises Series A+ Funding for CT X-Ray Tube Development
Beijing Smart Beam Technology, a leading vacuum electronic device maker, has reportedly raised “tens of...
Asieris Partners with ReviR Therapeutics for Urogenital Cancer Research
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has struck a...
Siemens Healthineers Reports Q1 Revenue Drop Amid COVID-19 Impact
Germany-based medical device giant Siemens Healthineers AG has released its fiscal year 2023 Q1 financial...
Astellas Pharma Reports Strong Q3 Results with 17.3% Revenue Growth
Japan-based Astellas Pharma Inc. (TYO: 4503) has released its financial report for Q3 of its...
Fujian Cosunter’s HBV Therapy GST-HG141 Begins Phase II Trial
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced the first patient enrollment and...
Harbour BioMed’s Anti-CCR8 Monoclonal Antibody HBM1022 Receives FDA IND Approval
Harbour BioMed (HBM), which operates out of the Netherlands, the United States, and Suzhou, China,...
Eli Lilly’s Tirzepatide Achieves Primary Endpoints in Chinese Obesity Study
US major Eli Lilly (NYSE: LLY) has announced that the Phase III SURMOUNT-CN study for...
Lifetech Partners with Jenscare for Structural Heart Disease Devices
China-based Lifetech Scientific Corporation (HKG: 1302) has announced a partnership agreement with compatriot firm Jenscare...
Gracell’s CAR-T Therapy GC012F Receives FDA IND Approval
Shanghai-based biotech Gracell Biotechnologies has reported receiving Investigational New Drug (IND) approval from the US...
Gilead Sciences Reports Q4 and Full-Year 2022 Financial Results
US major Gilead Sciences, Inc. (NASDAQ: GILD) last week reported Q4 and full-year 2022 financial...